Angiographic changes in saphenous vein grafts and atherosclerosis risk factors. A 5-year study with serial measurements of serum lipids and lipoproteins

Scandinavian Cardiovascular Journal

Volumn 32, Issue 6, 1998, Pages 343-351

  Korpilahti, K ^a,d   Engblom, E ^a   Syvanne M ^b   Hamalainen H ^c   Puukka, P ^c   Vanttinen E ^a   Ronnemaa T ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c SOCIAL INSURANCE INSTITUTION   (Finland)

^d VAASA CENTRAL HOSPITAL   (Finland)

Author keywords

Atherosclerosis risk factors; Coronary artery bypass grafting; Saphenous vein graft

Indexed keywords

APOLIPOPROTEIN E; FATTY ACID; LIPID; LIPOPROTEIN; LIPOPROTEIN A; MEGLUMINE IOXAGLATE PLUS SODIUM IOXAGLATE;

ADULT; ANGIOGRAPHY; ARTERY DIAMETER; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CATHETER; CLINICAL TRIAL; CORONARY ARTERY; CORONARY ARTERY BYPASS GRAFT; FEMALE; FOLLOW UP; GRAFT OCCLUSION; HUMAN; LIPID BLOOD LEVEL; LIPID COMPOSITION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SAPHENOUS VEIN GRAFT; STENOSIS; SUBCUTANEOUS FAT;

EID: 0031740559     PISSN: 14017431     EISSN: None     Source Type: Journal    
DOI: 10.1080/14017439850139799     Document Type: Article

References (39)

1. Grondin CM, Campeau L, Lespérance J, Enjalbert M, Bourassa MG. Comparison of late changes in internal mammary artery and saphenous vein grafts in two consecutive series of patients 10 years after operation. Circulation 1984; 70 Suppl I:I: 208-212.
2. Lytle BW, Loop FD, Cosgrove DM, Ratliff NB, Easley K, Taylor PC. Long-term (5 to 12 years) serial studies of internal mammary artery and saphenous vein coronary bypass grafts. J Thorac Cardiovasc Surg 1985; 89: 248-258.
3. Zeff RH, Kongtahworn C, Iannone LA, et al. Internal mammary artery versus saphenous vein graft to the left anterior descending coronary artery: prospective randomized study with 10-year follow up. Ann Thorac Surg 1988; 45: 533-536.
4. Grondin CM, Thornton JC. The natural history of saphenous vein grafts. In: Lüscher TF, Turina M, Braunwald E, eds. Coronary artery graft disease. Berlin-Heidelberg: Springer-Verlag, 1994: 3-15.
5. Lie JT, Lawrie GM, Morris GC. Aortocoronary bypass saphenous vein graft atherosclerosis. Anatomic study of 99 vein grafts from normal and hyperlipoproteinemic patients up to 75 months postoperatively. Am J Cardiol 1977; 40: 906-914.
6. Neitzel GF, Barboriak JJ, Pintar K, Qureshi I. Atherosclerosis in aortocoronary bypass grafts. Morphologic study and risk factor analysis 6 to 12 years after surgery. Arteriosclerosis 1986; 6: 594-600.
7. Solymoss BC, Nadeau P, Millette D, Campeau L. Late thrombosis of saphenous vein coronary bypass grafts related to risk factors. Circulation 1988; 78 Suppl I:I: 140-143.
8. Campeau L, Enjalbert M, Lespérance J, et al. The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. N Engl J Med 1984; 311: 1329-1332.
9. Lipton MJ, Takaro T, Clayman J, Maley T. Factors associated with long-term graft patency after coronary artery bypass surgery. Prog Cardiovasc Dis 1986; 28: 301-308.
10. Palac RT, Meadows WR, Hwang MH, Loeb HS, Pifarre R, Gunnar RM. Risk factors related to progressive narrowing in aortocoronary vein grafts studied 1 and 5 years after surgery. Circulation 1982; 66 Suppl I:I: 40-44.
11. The Post Coronary Artery Bypass Graft Trial Investigators. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts. N Engl J Med 1997; 336: 153-162.
12. Engblom E, Rönnemaa T, Hämäläinen H, Kallio V, Vänttinen E, Knuts LR. Coronary heart disease risk factors before and after bypass surgery: results of a controlled trial on multifactorial rehabilitation. Eur Heart J 1992; 13: 232-237.
13. Engblom E, Korpilahti K, Hämäläinen H, Puukka P, Rönnemaa T. Effects of five years of cardiac rehabilitation after coronary artery bypass grafting on coronary risk factors. Am J Cardiol 1996; 78: 1428-1431.
14. Engblom E, Korpilahti K, Hämäläinen H, Rönnemaa T, Puukka P. Quality of life and return to work 5 years after coronary artery bypass surgery. Long-term results of cardiac rehabilitation. J Cardiopulmonary Rehabil 1997; 17: 29-36.
15. Campeau L. Grading of angina pectoris. Letter. Circulation 1976; 54: 522-523.
16. Reiber JHC, van der Zwet PMJ, von Land CD, et al. Quantitative coronary arteriography: equipment and technical requirements. In: Reiber JHC, Serruys PW, eds. Advances in quantitative coronary arteriography. Dordrecht: Kluwer Academic Publishers, 1993: 75-111.
17. Syvänne M, Nieminen MS, Frick MH. Accuracy and precision of quantitative arteriography in the evaluation of coronary artery disease after coronary bypass surgery. A validation study. Int J Vascular Imaging 1994; 10: 243-252.
18. Reiber JHC, Serruys PW, Kooijman CJ, et al. Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms. Circulation 1985; 71: 280-288.
19. Siegel J, Schlumberger H, Klose S, Ziegenhorn J, Wahlefeld AW. Improved reagent for the enzymatic determination of serum cholesterol. J Clin Chem Clin Biochem 1981; 19: 838-839.
20. Wahlefeld AW. Triglycerides-determination after enzymatic hydrolysis. In: Bergmeyer HV, ed. Methods of enzymatic analysis. 2nd edition. New York: Verlag Chemie/Academic Press, 1974: 1831-1835.
21. Kostner G. Enzymatic determination of cholesterol in high-density lipoprotein fractions prepared by polyanion precipitation. Clin Chem 1976; 22: 695.
22. Friedewald W, Levy R, Fredrickson D. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
23. März W, Siekmeier R, Gross E, Gross W. Determination of lipoprotein (a): enzyme immunoassay and immunoradiometric assay compared. Clin Chem Acta 1993; 214: 153-163.
24. Riepponen P, Marniemi J, Rautaoja T. Immunoturbidimetric determination of apolipoproteins A-1 and B in serum. Scand J Clin Lab Invest 1987; 47: 739-744.
25. Lehtimäki T, Moilanen T, Viikari J, et al. Apolipoprotein E phenotypes in Finnish youths: a cross-sectional and 6-year follow-up study. J Lipid Res 1990; 31: 487-495.
26. Cederholm J, Wibell L. Insulin release and peripheral sensitivity at the oral glucose tolerance test. Diabetes Res Clin Pract 1990; 10: 167-175.
27. Marniemi J, Lehtonen A, Inberg M, et al. Fatty acid composition of serum lipids in patients with a coronary bypass operation. J Int Med 1989; 225: 343-347.
28. Marshall MD, Kales SN, Christiani DC, Goldman RH. Are reference intervals for carboxyhemoglobin appropriate? A survey of Boston area laboratories. Clin Chem 1995; 41: 1434-1438.
29. Daida H, Yokoi H, Miyano H, et al. Relation of saphenous vein graft obstruction to serum cholesterol levels. J Am Coll Cardiol 1995; 25: 193-197.
30. Goldman S, Zadina K, Krasnicka B, et al. Predictors of graft patency 3 years after coronary artery bypass graft surgery. J Am Coll Cardiol 1997; 29: 1563-1568.
31. Hoff HF, Beck GJ, Skibinski CI, et al. Serum Lp(a) level as a predictor of vein graft stenosis after coronary artery bypass surgery in patients. Circulation 1988; 7: 1238-1244.
32. Blankenhorn DH, Azen SP, Kramsch DM, et al. Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS). Ann Intern Med 1993; 119: 969-976.
33. Cashin-Hemphill L, Mack WJ, Pogoda JM, Sanmarco ME, Azen SP, Blankenhorn DH. Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up. JAMA 1990; 264: 3013-3017.
34. Cavender JB, Rogers WJ, Fisher LD, Gersh BJ, Coggin CJ, Myers WO for the CASS investigators. Effects of smoking on survival and morbidity in patients randomized to medical or surgical therapy in the coronary artery surgery study (CASS): 10-year follow-up. J Am Coll Cardiol 1992; 20: 287-294.
35. Voors AA, van Brussel BL, Plokker HWT, et al. Smoking and cardiac events after venous coronary bypass surgery. A 15-year follow-up study. Circulation 1996; 93: 42-47.
36. FitzGibbon GM, Leach AJ, Kafka HP. Atherosclerosis of coronary artery bypass grafts and smoking. Can Med Assoc J 1987; 136: 45-47.
37. Ip JH, Fuster V, Badimon L, Badimon J, Taubman MB, Chesebro JH. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol 1990; 15: 1667-1687.
38. Amano J, Suzuki A, Sunamori M, Tsukada T, Numano F. Cytokinetic study of aortocoronary bypass vein grafts in place for less than six months. Am J Cardiol 1991; 67: 1234-1236.
39. Angelini GD, Newby AC. The future of saphenous vein as a coronary artery bypass conduit. Eur Heart J 1989; 10: 273-280.